ARROWHEAD PHARMACEUTICALS IN (ARWR) Institutional Ownership and Insiders Activity

ARROWHEAD PHARMACEUTICALS IN (ARWR) is widely held by institutional investors, with 484 firms reporting positions valued at approximately $9.65B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $1.21B in ARWR holdings in its latest filing.

Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.